세포 생존력 분석 시장 : 제품 유형, 세포 유형, 응용 분야 및 최종 사용자별 - 세계 예측(2025-2030년)

The Cell Viability Assays Market was valued at USD 1.79 billion in 2023, expected to reach USD 1.99 billion in 2024, and is projected to grow at a CAGR of 11.38%, to USD 3.82 billion by 2030.

Cell viability assays are critical analytical techniques used to assess the health and functionality of cells in various research and clinical settings. They are essential for measuring cell proliferation, metabolism, cytotoxicity, and apoptosis, aiding in drug development, cancer research, and toxicity testing. The application of cell viability assays spans pharmaceuticals, biotechnology, medical research, and environmental monitoring, with end-users including academic institutions, healthcare facilities, and biopharmaceutical companies. Currently, market growth is driven by increased R&D investments in life sciences, the prevalence of chronic diseases requiring innovative treatment options, and technological advancements in assay techniques offering higher sensitivity and throughput. However, challenges such as high costs associated with sophisticated assay systems and stringent regulatory landscapes can impede growth. Additionally, the complexity of interpreting data from multidimensional assays poses limitations. Despite these challenges, the industry is ripe with opportunities. Integration of artificial intelligence for data analysis, development of 3D cell cultures, and miniaturization of assay platforms offer promising avenues for innovation. Moreover, emerging markets in Asia-Pacific provide growth potential due to expanding healthcare infrastructure and supportive governmental policies. For market players, focusing on collaborative research initiatives, strategic partnerships, and expanding their presence in untapped regions are recommended strategies to capitalize on growth opportunities. Moreover, investments in developing cost-effective and user-friendly products could significantly enhance market penetration. The evolving nature of the market, with its shift towards personalized medicine and regenerative therapies, underscores the need for continuous innovation and adaptation. Companies that prioritize incorporating next-gen technologies and address existing client pain points stand to gain a competitive edge. Overall, a nuanced understanding of market dynamics and consumer needs will be critical for sustained business growth in the cell viability assays domain.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Viability Assays Market

The Cell Viability Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing investments in cell-based research
  • Rising number of clinical trials in economies
  • Utilization of cell viability assays to screen water bodies
• Market Restraints
  • High cost of reagents and cell viability assays
• Market Opportunities
  • Development of highly sensitive and rapid protocol cell viability assays
  • Adoption of cell viability in quality control operations
• Market Challenges
  • Technical limitations of cell viability assay

Porter's Five Forces: A Strategic Tool for Navigating the Cell Viability Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Viability Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Viability Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Viability Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Viability Assays Market

A detailed market share analysis in the Cell Viability Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Viability Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Viability Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Viability Assays Market

A strategic analysis of the Cell Viability Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Viability Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Agilent Technologies, Inc., Akadeum Life Sciences, Assay Genie, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biotium, Inc., BMG LABTECH GmbH, Cell Biolabs, Inc., Creative Bioarray, Danaher Corporation, Elabscience Biotechnology Inc., Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., Hemogenix Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer, Inc., Promega Corporation, Qiagen N.V., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Viability Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits, Microplates, and Reagents. The Assay Kits is further studied across Colorimetric assays, Dye exclusion assays, Fluorometric assays, and Luminometric assays. The Instruments is further studied across Cell Imaging & Analysis System, Flow Cytometry, Microscopy, and Spectrophotometer.
• Based on Cell Type, market is studied across Animal Cells, Human Cells, and Microbial Cells.
• Based on Application, market is studied across Basic Research, Clinical & Diagnostic Applications, Drug Discovery & Development, and Stem Cell Research.
• Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing investments in cell-based research
    • 5.1.1.2. Rising number of clinical trials in economies
    • 5.1.1.3. Utilization of cell viability assays to screen water bodies
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of reagents and cell viability assays
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of highly sensitive and rapid protocol cell viability assays
    • 5.1.3.2. Adoption of cell viability in quality control operations
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations of cell viability assay
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Viability Assays Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
    • 6.2.1.1. Colorimetric assays
    • 6.2.1.2. Dye exclusion assays
    • 6.2.1.3. Fluorometric assays
    • 6.2.1.4. Luminometric assays
  • 6.2.2. Microplates
  • 6.2.3. Reagents
• 6.3. Instruments
  • 6.3.1. Cell Imaging & Analysis System
  • 6.3.2. Flow Cytometry
  • 6.3.3. Microscopy
  • 6.3.4. Spectrophotometer

7. Cell Viability Assays Market, by Cell Type

• 7.1. Introduction
• 7.2. Animal Cells
• 7.3. Human Cells
• 7.4. Microbial Cells

8. Cell Viability Assays Market, by Application

• 8.1. Introduction
• 8.2. Basic Research
• 8.3. Clinical & Diagnostic Applications
• 8.4. Drug Discovery & Development
• 8.5. Stem Cell Research

9. Cell Viability Assays Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospital & Diagnostic Laboratories
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Cell Viability Assays Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Viability Assays Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Viability Assays Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AAT Bioquest, Inc.
• 2. Abcam PLC
• 3. Agilent Technologies, Inc.
• 4. Akadeum Life Sciences
• 5. Assay Genie
• 6. Becton, Dickinson and Company
• 7. Bio-Rad Laboratories, Inc.
• 8. Bio-Techne Corporation
• 9. Biotium, Inc.
• 10. BMG LABTECH GmbH
• 11. Cell Biolabs, Inc.
• 12. Creative Bioarray
• 13. Danaher Corporation
• 14. Elabscience Biotechnology Inc.
• 15. Enzo Life Sciences, Inc.
• 16. F. Hoffmann-La Roche AG
• 17. GE HealthCare Technologies, Inc.
• 18. Hemogenix Inc.
• 19. Illumina, Inc
• 20. Merck KGaA
• 21. Miltenyi Biotec B.V. & Co. KG
• 22. PerkinElmer, Inc.
• 23. Promega Corporation
• 24. Qiagen N.V.
• 25. Thermo Fisher Scientific, Inc.